About
Dr. Salvatore Simmini is an R&D Senior Scientist in the Gastrointestinal Biology Group at STEMCELL Technologies. His group focuses on developing products that support generation of 3D gastrointestinal organoid cultures both from human primary tissue and from human pluripotent stem cells. Prior to joining STEMCELL Technologies in 2016, Dr. Simmini obtained his PhD in Stem Cells, Developmental Biology and Cancer at the University of Utrecht. During that time, he performed his research in the group of Dr. Jacqueline Deschamps at the Hubrecht Institute in Utrecht, where he investigated molecular mechanisms controlled by transcription factor Cdx2 in adult mouse intestinal stem cells and during embryonic development. In 2015, he did his postdoc joining the group of Dr. Jan Paul Medema and Dr. Louis Vermeulen at the Amsterdam Medical Centre (AMC) in Amsterdam, where he investigated mechanisms regulating intestinal stem cell proliferation and differentiation in colorectal cancer. He is also currently involved in several European Grant Council projects as principal investigator.
About STEMCELL Technologies
STEMCELL Technologies Inc. is a privately-owned biotechnology company based in Vancouver that helps power leading-edge life science research around the world. Scientists performing stem cell, immunology, cancer, regenerative medicine and cellular therapy research are among those who rely on our cell culture media, cell separation products, instruments, ancillary reagents and contract assay services. We create novel, useful, standardized products of unfailing quality and deliver them to more than 70 countries via our many regional offices plus distribution centres in Vancouver, Seattle, Grenoble and Singapore. Driven by our love of science and our passion for quality, we see ourselves simply as “Scientists Helping Scientists” – standing by our customers to provide outstanding products, technical support and training. We have over 1000 science-oriented employees globally, including 250 PhDs/MScs, with most others holding a BSc or engineering degree. STEMCELL is proud to be the largest Biotechnology employer in Canada.
STEMCELL is continuing to expand its European operations, particularly in the areas of R&D personnel and facilities, manufacturing, quality control, quality assurance and regulatory activities that will meet the highest levels of European research and regular standards. STEMCELL UK Ltd. (STUK) was established in July 2014. In 2016 STUK expanded its capabilities to include research and development (R&D) with staff located in laboratory space in Cambridge, UK, including fully functional laboratory space containing state of the art cell culture and analytical chemistry equipment as well as an ISO 13485-certified manufacturing clean room that is adopting single use technology and closed systems for manufacturing higher compliance media and culture reagents.
